FDA Inspection 1333776 — Eurofins Pharma Quality Control
The FDA completed an inspection of Eurofins Pharma Quality Control on Apr 1, 2026 in Ste Croix en Plaine. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 1, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ste Croix en Plaine (France)
Additional Details
Mutual Recognition Agreement (MRA)